REGENXBIO Inc. (RGNX) Operating margin 2016–2025
REGENXBIO Inc. (RGNX) operating margin by fiscal year — reported operating income divided by reported revenue.
-94.6%FY2025 · since FY2016: -1423.8% → -94.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -94.6% | +185.5 pp |
| FY2024 | -280.0% | +17.1 pp |
| FY2023 | -297.1% | -63.9 pp |
| FY2022 | -233.2% | -267.2 pp |
| FY2021 | 34.0% | +111.2 pp |
| FY2020 | -77.1% | +345.8 pp |
| FY2019 | -422.9% | -463.2 pp |
| FY2018 | 40.3% | +770.5 pp |
| FY2017 | -730.2% | +693.7 pp |
| FY2016 | -1423.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice